1. Targeting Neoantigens for Personalised Immunotherapy

   • Antonia L. Pritchard

   Leading Article 08 March 2018 Pages: 99 - 109

2. Interleukin-1 Blockade in Cardiovascular Diseases: From Bench to Bedside

   • Leo F Buckley
   • Antonio Abbate

   Leading Article 16 March 2018 Pages: 111 - 118

   

3. Guselkumab for the Treatment of Psoriasis

   • Álvaro Machado
   • Tiago Torres

   Review Article 22 February 2018 Pages: 119 - 128

   

4. Epoetin Biosimilars in the Treatment of Chemotherapy-Induced Anemia: 10 Years’ Experience Gained

   • Matti Aapro
   • Andriy Krendyukov
   • Pere Gascón

   Review Article Open access 07 February 2018 Pages: 129 - 135

   

5. Correction to: Epoetin Biosimilars in the Treatment of Chemotherapy-Induced Anemia: 10 Years’ Experience Gained

   • Matti Aapro
   • Andriy Krendyukov
   • Pere Gascón

   Correction 28 February 2018 Pages: 137 - 138

   

6. Benefit Versus Risk Assessment of Rotavirus Vaccination in France: A Simulation and Modeling Analysis

   • Edouard Ledent
   • Hugo Arlegui
   • Gaëlle Nachbaur

   Original Research Article Open access 27 March 2018 Pages: 139 - 152

   

7. Comprehensive Physicochemical and Biological Characterization of the Proposed Biosimilar Darbepoetin Alfa, LBDE, and Its Originator Darbepoetin Alfa, NESP^®

   • Yeong Ran Jeong
   • Rae Ung Jeong
   • Gyun Min Lee

   Original Research Article 19 March 2018 Pages: 153 - 168

   

8. Plasma Pharmacokinetics of Valanafusp Alpha, a Human Insulin Receptor Antibody-Iduronidase Fusion Protein, in Patients with Mucopolysaccharidosis Type I

   • William M. Pardridge
   • Ruben J. Boado
   • Mathias Schmidt

   Original Research Article 13 February 2018 Pages: 169 - 176

   

9. Comment on: LY2963016 Insulin Glargine: A Review in Type 1 and 2 Diabetes

   • Riccardo Perfetti

   Letter to the Editor Open access 15 March 2018 Pages: 177 - 177

10. Authors’ Reply to Dr. Riccardo Perfetti: “LY2963016 Insulin Glargine: A Review in Type 1 and 2 Diabetes”

    • Yvette N. Lamb
    • Yahiya Y. Syed

    Letter to the Editor 15 March 2018 Pages: 179 - 179

11. Correction to: LY2963016 Insulin Glargine: A Review in Type 1 and 2 Diabetes

    • Yvette N. Lamb
    • Yahiya Y. Syed

    Correction 06 March 2018 Pages: 181 - 181